Cladribine Tablets and Relapsing–Remitting Multiple Sclerosis: A Pragmatic, Narrative Review of What Physicians Need to Know

Cladribine Tablets and Relapsing–Remitting Multiple Sclerosis: A Pragmatic, Narrative Review of What Physicians Need to Know

Abstract Immune reconstitution therapy (IRT) is an emerging management concept for multiple sclerosis, whereby a short course of treatment provides long-lasting suppression of disease activity. “Cladribine tablets 10 mg” refers to a total cumulative dose of cladribine given over 2 years (henceforth...

Full description

Bibliographic Details
Main Authors: Mohamed AlJumah, Mona Marwan Alkhawajah, Shireen Qureshi, Ibtisam Al-Thubaiti, Omar Ayoub, Saeed A. Bohlega, Areej Bushnag, Edward Cupler, Abdulkader Daif, Ahmed El Boghdady, Ahmed Hassan, Yaser Al Malik, Jameelah Saeedi, Fawzia Al-Shamrany, Eslam Shosha, Peter Rieckmann
Format: Article
Language:English
Published: Adis, Springer Healthcare 2020-02-01
Series:Neurology and Therapy
Subjects:
Cladribine tablets
Disease-modifying drugs
Immune reconstitution therapy
Relapsing–remitting multiple sclerosis
Online Access:https://doi.org/10.1007/s40120-020-00177-5

Internet

https://doi.org/10.1007/s40120-020-00177-5

Similar Items